147 related articles for article (PubMed ID: 8628138)
1. Managing HIV. Part 3: Mechanisms of disease. 3.3 How HIV leads to opportunistic infections.
Crowe SM; Kornbluth RS
Med J Aust; 1996 Feb; 164(3):171-3. PubMed ID: 8628138
[TBL] [Abstract][Full Text] [Related]
2. Natural history and spectrum of disease in adults with HIV/AIDS in Africa.
Grant AD; Djomand G; De Cock KM
AIDS; 1997; 11 Suppl B():S43-54. PubMed ID: 9416366
[TBL] [Abstract][Full Text] [Related]
3. Immune responses against HIV: what we want and what we get.
Smith D
J HIV Ther; 2002 May; 7(2):27-9. PubMed ID: 12553684
[No Abstract] [Full Text] [Related]
4. [Effect of opportunistic infections on the frequency of leukocyte subpopulations from type-1 human immunodeficiency virus infected individuals].
Ramírez Z; Cataño JC; Román A; Rugeles MT; Montoya CJ
Biomedica; 2008 Mar; 28(1):64-77. PubMed ID: 18645662
[TBL] [Abstract][Full Text] [Related]
5. Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease.
Toossi Z
J Infect Dis; 2003 Oct; 188(8):1146-55. PubMed ID: 14551885
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART.
Jones LE; Perelson AS
Bull Math Biol; 2005 Nov; 67(6):1227-51. PubMed ID: 16023709
[TBL] [Abstract][Full Text] [Related]
7. 'Tuberculosis' after commencing antiretroviral therapy in HIV patients from countries where Mycobacterium tuberculosis infection is common.
French MA
AIDS; 2006 Feb; 20(3):473-4. PubMed ID: 16439889
[No Abstract] [Full Text] [Related]
8. HIV infection and AIDS.
Lloyd A
P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
[TBL] [Abstract][Full Text] [Related]
9. [Gastrointestinal leishmaniasis in patients infected with the human immunodeficiency virus].
Laguna F; Soriano V; Valencia E; González-Lahoz JM
Rev Clin Esp; 1994 Jun; 194(6):510-1. PubMed ID: 8079027
[No Abstract] [Full Text] [Related]
10. Emergencies in HIV--part 2.
Rewari BB; Purohit V; Chhabra RM; Bhagwan J
J Assoc Physicians India; 2008 Oct; 56():783-6. PubMed ID: 19263705
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons.
Geertsma MF; van Wengen-Stevenhagen A; van Dam EM; Risberg K; Kroon FP; Groeneveld PH; Nibbering PH
J Infect Dis; 1999 Sep; 180(3):649-58. PubMed ID: 10438351
[TBL] [Abstract][Full Text] [Related]
12. Influence of microbial infections on the progression of HIV disease.
Blanchard A; Montagnier L; Gougeon ML
Trends Microbiol; 1997 Aug; 5(8):326-31. PubMed ID: 9263412
[TBL] [Abstract][Full Text] [Related]
13. [Treatment and prophylaxis of opportunistic infections in individuals infected with HIV].
Salemović D; Jevtović Dj; Brmbolić B; Ranin J; Tucaković M
Srp Arh Celok Lek; 1992 Nov; 120 Suppl 5():17-21. PubMed ID: 18170971
[TBL] [Abstract][Full Text] [Related]
14. [Natural history of the HIV infection and changes in the central nervous system].
Gładysz A; Szymczak A; Simon K
Przegl Epidemiol; 2002; 56 Suppl 1():6-16. PubMed ID: 12194231
[TBL] [Abstract][Full Text] [Related]
15. Impaired humoral responses to subgenus D adenovirusenovirus infections in HIV-positive patients.
Lord A; Bailey AS; Klapper PE; Snowden N; Khoo SH
J Med Virol; 2000 Dec; 62(4):405-9. PubMed ID: 11074466
[TBL] [Abstract][Full Text] [Related]
16. [HIV and dentistry. Part 3. HIV infection: pathogenesis, epidemiology, definitions and classification].
Schulten EA; Danner SA; Sjamsoedin DA; van der Waal I
Ned Tijdschr Tandheelkd; 1994 Mar; 101(3):81-5. PubMed ID: 11830955
[TBL] [Abstract][Full Text] [Related]
17. The neuropathology of adult HIV infection.
Bell JE
Rev Neurol (Paris); 1998 Dec; 154(12):816-29. PubMed ID: 9932303
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma.
Kersten MJ; Klein MR; Holwerda AM; Miedema F; van Oers MH
J Clin Invest; 1997 Apr; 99(7):1525-33. PubMed ID: 9119996
[TBL] [Abstract][Full Text] [Related]
19. Experiences in immune reconstitution. The rationale for interleukin-2 administration to HIV-infected individuals.
Ghezzi S; Vicenzi E; Soldini L; Tambussi G; Murone M; Lazzarin A; Poli G
J Biol Regul Homeost Agents; 1997; 11(1-2):74-8. PubMed ID: 9418168
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis in patients with HIV infection.
Ortona L; Antinori A
Rays; 1998; 23(1):78-86. PubMed ID: 9673137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
